Cargando…

Effects of PPARD gene variants on the therapeutic responses to exenatide in chinese patients with type 2 diabetes mellitus

BACKGROUND: Exenatide is a GLP-1R agonist that often exhibits considerable interindividual variability in therapeutic efficacy. However, there is no evidence about the impact of genetic variants in the PPARD on the therapeutic efficacy of exenatide. This research was aimed to explore the influence o...

Descripción completa

Detalles Bibliográficos
Autores principales:	Song, Jinfang, Li, Na, Hu, Ruonan, Yu, Yanan, Xu, Ke, Ling, Hongwei, Lu, Qian, Yang, Tingting, Wang, Tao, Yin, Xiaoxing
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Endocrinology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9424689/ https://www.ncbi.nlm.nih.gov/pubmed/36051387 http://dx.doi.org/10.3389/fendo.2022.949990

Ejemplares similares

Variants of the PPARD Gene and Their Clinicopathological Significance in Colorectal Cancer
por: Ticha, Ivana, et al.
Publicado: (2013)

PPARD rs2016520 (T/C) and NOS1AP rs12742393 (A/C) polymorphisms affect therapeutic efficacy of nateglinide in Chinese patients with type 2 diabetes mellitus
por: Wang, Tao, et al.
Publicado: (2021)

Polymorphism of the PPARD Gene and Dynamic Balance Performance in Han Chinese Children
por: Cao, Yixuan, et al.
Publicado: (2019)

Exenatide Improves Bone Quality in a Murine Model of Genetically Inherited Type 2 Diabetes Mellitus
por: Pereira, Marie, et al.
Publicado: (2017)

The Changes of Lipidomic Profiles Reveal Therapeutic Effects of Exenatide in Patients With Type 2 Diabetes
por: Zhang, Lin, et al.
Publicado: (2022)

Single Nucleotide Polymorphisms in PPARD Associated with Systemic Lupus Erythematosus in Chinese Populations
por: Qi, Yuan-yuan, et al.
Publicado: (2020)

Associations of Type 2 Diabetes with Common Variants in PPARD and the Modifying Effect of Vitamin D among Middle-Aged and Elderly Chinese
por: Lu, Ling, et al.
Publicado: (2012)

PPARD is an Inhibitor of Cartilage Growth in External Ears
por: Zhang, Zhen, et al.
Publicado: (2017)

The Effect of Exenatide on Cardiovascular Risk Markers in Women With Polycystic Ovary Syndrome
por: Dawson, Alison J., et al.
Publicado: (2019)

Exenatide Attenuates Non-Alcoholic Steatohepatitis by Inhibiting the Pyroptosis Signaling Pathway
por: Liu, Yu, et al.
Publicado: (2021)

Exenatide improves hepatocyte insulin resistance induced by different regional adipose tissue
por: Bai, Chuanmin, et al.
Publicado: (2022)

The Impact of PPARD and PPARG Polymorphisms on Glioma Risk and Prognosis
por: Ding, Xiaoying, et al.
Publicado: (2020)

Identifying the Metabolic Signatures of PPARD-Overexpressing Gastric Tumors
por: Pudakalakatti, Shivanand, et al.
Publicado: (2022)

Exenatide once weekly for the treatment of type 2 diabetes: effectiveness and tolerability in patient subpopulations
por: Pencek, R, et al.
Publicado: (2012)

Exenatide Protects Against Cardiac Dysfunction by Attenuating Oxidative Stress in the Diabetic Mouse Heart
por: Ding, Wei, et al.
Publicado: (2019)

PPARD +294C overrepresentation in general and long-lived population in China Bama longevity area and unique relationships between PPARD +294T/C polymorphism and serum lipid profiles
por: Luo, Chen-Yuan, et al.
Publicado: (2015)

PPARD May Play a Protective Role for Major Depressive Disorder
por: Yang, Tao, et al.
Publicado: (2021)

Exenatide Attenuates Obesity-Induced Mitochondrial Dysfunction by Activating SIRT1 in Renal Tubular Cells
por: Wang, Yao, et al.
Publicado: (2021)

Brain Activation in Response to Low-Calorie Food Pictures: An Explorative Analysis of a Randomized Trial With Dapagliflozin and Exenatide
por: van Ruiten, Charlotte C., et al.
Publicado: (2022)

Adolescents with obesity treated with exenatide maintain endogenous GLP-1, reduce DPP-4, and improve glycemic control
por: Stenlid, Rasmus, et al.
Publicado: (2023)

Obesity-Related Genetic Variants and Hyperuricemia Risk in Chinese Men
por: Ma, Zhimin, et al.
Publicado: (2019)

Association of ACE2 gene functional variants with gestational diabetes mellitus risk in a southern Chinese population
por: Huang, Gongchen, et al.
Publicado: (2022)

A Multicenter Survey of Type I Diabetes Mellitus in Chinese Children
por: Hou, Ling, et al.
Publicado: (2021)

Addition of exenatide twice daily to basal insulin for the treatment of type 2 diabetes: clinical studies and practical approaches to therapy
por: Tobin, G S, et al.
Publicado: (2012)

The G32E Functional Variant Reduces Activity of PPARD by Nuclear Export and Post-Translational Modification in Pigs
por: Duan, Yanyu, et al.
Publicado: (2013)

Integrative and systemic approaches for evaluating PPARβ/δ (PPARD) function
por: Giordano Attianese, Greta MP, et al.
Publicado: (2015)

PPARD May Play a Protective Role against the Development of Schizophrenia
por: Li, Xinrong, et al.
Publicado: (2020)

Association between GLO1 variants and gestational diabetes mellitus susceptibility in a Chinese population: a preliminary study
por: Zeng, Qiaoli, et al.
Publicado: (2023)

Integrated lipids biomarker of the prediabetes and type 2 diabetes mellitus Chinese patients
por: Yang, Jiaying, et al.
Publicado: (2023)

The GLP-1 Receptor Agonist Exenatide Ameliorates Bone Composition and Tissue Material Properties in High Fat Fed Diabetic Mice
por: Mansur, Sity Aishah, et al.
Publicado: (2019)

Evolution of Exenatide as a Diabetes Therapeutic
por: Bhavsar, Sunil, et al.
Publicado: (2013)

Integration of clinical demographics and routine laboratory analysis parameters for early prediction of gestational diabetes mellitus in the Chinese population
por: Zhang, Hesong, et al.
Publicado: (2023)

Weight Loss Outcomes Among Early High Responders to Exenatide Treatment: A Randomized, Placebo Controlled Study in Overweight and Obese Women
por: Rodgers, Megan, et al.
Publicado: (2021)

Exenatide Use in the Management of Type 2 Diabetes Mellitus
por: Kyriacou, Angelos, et al.
Publicado: (2010)

Novel Genetic Variants of PPARγ2 Promoter in Gestational Diabetes Mellitus and its Molecular Regulation in Adipogenesis
por: Wu, Ling, et al.
Publicado: (2021)

Clinical Characteristics of Inpatients With New-Onset Diabetes Mellitus in Eastern China: Based on Novel Clustering Analysis
por: Song, Xueke, et al.
Publicado: (2022)

Relationship between plasma glutamate and cardiovascular disease risk in Chinese patients with type 2 diabetes mellitus by gender
por: Li, Ru-Tao, et al.
Publicado: (2023)

An early prediction model for type 2 diabetes mellitus based on genetic variants and nongenetic risk factors in a Han Chinese cohort
por: Li, Jinjin, et al.
Publicado: (2023)

Efficacy and safety of exenatide once‐weekly vs exenatide twice‐daily in Asian patients with type 2 diabetes mellitus
por: Ji, Linong, et al.
Publicado: (2013)

Effects of exenatide and liraglutide on heart rate, blood pressure and body weight: systematic review and meta-analysis
por: Robinson, Louise E, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_pqa77ropfu0iqoov2fuj3dbv16